profit from every $100 of sales.

Baird Medical Investment Holdings Ltd Warrant
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
It has no yearly profit to compare the price with.
of earnings would pay off all its debt.
Money in, money out
What Baird Medical Investment Holdings Ltd Warrant sold, what it kept, and what it did with the cash.
Sales went from $35.1 million in 2022 to $22.5 million in 2025, with -$27.3 million of profit last year.
Baird Medical Investment Holdings Ltd Warrant vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
Baird Medical Investment Holdings Ltd Warrant | No profit yet | ||
Petroleo Brasileiro S.A.-Petrobras | 1.0× · Cheap | ||
Companhia Energetica De Minas Gerais-CEMIG | 9.9× · Cheap | ||
Embotelladora Andina S.A. Series B | 15.8× · Fair price | ||
Bluerock Private Real Estate Fund | No profit yet |
AI analysis
An AI analyst reads Baird Medical Investment Holdings Ltd Warrant's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 35 | 31 | 37 | 23 | |
| 28 | 27 | 33 | 19 | |
| 15 | 13 | 15 | -26 | |
| 16 | 14 | 16 | -25 | |
| 13 | 11 | 12 | -27 | |
| – | – | – | – | |
| 79.9% | 86.6% | 88.2% | 83.8% | |
| 42.8% | 40.2% | 41.4% | -113.3% | |
| 35.8% | 33.5% | 33.6% | -121.0% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 43 | 57 | 78 | 70 |
| Cash | 2 | 2 | 3 | 0 |
| Total debt | 7 | 12 | 21 | 19 |
| Total liabilities | 17 | 21 | 38 | 38 |
| 26 | 36 | 40 | 31 | |
| – | – | – | – | |
| 35.1% | 21.1% | 19.1% | -40.0% | |
| 48.5% | 29.5% | 31.4% | -87.0% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 0 | -1 | -6 | -1 | |
| 6 | 3 | 3 | 0 | |
| -5 | -4 | -9 | -1 | |
| Dividends paid | 0 | – | – | – |
| – | – | – | – | |
| – | 0 | 0 | 17 |
Valuation
- –
- –
- –
- –
- –
- –
- –
- –
- –
- –
Profitability
- 83.8%
- -113.3%
- -121.0%
- –
- –
- 0.0%
- –
- –
- –
- –
Growth
- −13.7%
- –
- –
- –
- +0.0%
Financial health
- –
- –
- –
- –
- –
- –
- –
News
Baird Cut Its Nvidia (NVDA) Target From $500 to $200. Here’s What It Wants NextYahoo Finance · Nov 12, 2026NVIDIA Rises 4% Despite Baird Downgrade and Huang Uncertainty; AMD Climbs 5%, Broadcom Gains 4%Yahoo Finance · Nov 11, 2026Baird Raises Apple Target to $340 Despite Post-Earnings DropYahoo Finance · Nov 3, 2026Deere and AGCO Rally 4% as Baird Upgrades Both on North America Row Crop DemandYahoo Finance · Aug 31, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
Not enough data
Questions about Baird Medical Investment Holdings Ltd Warrant
Is Baird Medical Investment Holdings Ltd Warrant a good stock to buy?
A business with weak numbers that is not profitable yet. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Baird Medical Investment Holdings Ltd Warrant AI analysis
Does Baird Medical Investment Holdings Ltd Warrant pay a dividend?
No. Baird Medical Investment Holdings Ltd Warrant does not pay a dividend at the moment.
Who are Baird Medical Investment Holdings Ltd Warrant's competitors?
The largest listed companies in the same industry are Petroleo Brasileiro S.A.-Petrobras, Companhia Energetica De Minas Gerais-CEMIG, Embotelladora Andina S.A. Series B and Bluerock Private Real Estate Fund. The peers table on this page compares their profit, growth and price with Baird Medical Investment Holdings Ltd Warrant's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.



